Mikael Eriksson Selected Research

Mikael Eriksson Research Topics

Disease

64	Breast Neoplasms (Breast Cancer) 02/2024 - 12/2010
39	Neoplasms (Cancer) 02/2024 - 08/2009
14	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 02/2006
8	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 03/2012
7	Genetic Risk Score 02/2024 - 05/2015
6	Osteosarcoma (Osteogenic Sarcoma) 11/2023 - 06/2013
6	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2011
4	Lymphoma (Lymphomas) 03/2024 - 08/2012
4	Sepsis (Septicemia) 02/2024 - 01/2017
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2016 - 08/2003
4	Testicular Neoplasms (Testicular Cancer) 02/2006 - 06/2003
3	Triple Negative Breast Neoplasms 01/2023 - 01/2019
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 10/2008
3	Male Breast Neoplasms (Male Breast Cancer) 10/2020 - 12/2010
3	Uveal melanoma 10/2020 - 01/2012
3	Wounds and Injuries (Trauma) 12/2019 - 09/2015
3	Necrosis 01/2018 - 06/2013
2	Hairy Cell Leukemia 01/2023 - 05/2002
2	Human Influenza (Influenza) 05/2022 - 06/2014
2	Hypertension (High Blood Pressure) 05/2022 - 12/2016
2	Shock 08/2021 - 01/2017
2	Calcinosis 01/2021 - 01/2017
2	Pre-Eclampsia (Preeclampsia) 01/2018 - 12/2016
2	Familial Breast Cancer 11/2017 - 02/2015
2	Breast Diseases (Breast Disease) 01/2017 - 09/2014
2	Infections 10/2016 - 06/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2015 - 11/2012
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2015 - 08/2009
1	Pneumonia (Pneumonitis) 02/2024
1	Hot Flashes 01/2023
1	Vaginal Discharge 01/2023
1	Muscle Cramp (Cramp) 01/2023
1	Obesity 11/2022
1	Overweight 11/2022
1	COVID-19 05/2022
1	Fatigue 01/2022
1	Liposarcoma 01/2022
1	Nausea 01/2022
1	Thoracic Injuries (Chest Injury) 08/2021
1	Fibroadenoma 01/2021
1	Chondrosarcoma 01/2021

Drug/Important Bio-Agent (IBA)

23	Estrogen ReceptorsIBA 01/2023 - 01/2014
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2003
11	Hormones (Hormone)IBA 01/2022 - 12/2010
9	Tamoxifen FDA LinkGeneric 01/2023 - 07/2015
9	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 03/2012
7	ORALIT (ORS)IBA 03/2022 - 02/2006
5	Phenobarbital (Luminal)FDA Link 12/2022 - 11/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
4	Polychlorinated Biphenyls (PCBs)IBA 10/2020 - 06/2003
4	Endocrine DisruptorsIBA 09/2012 - 06/2003
3	PesticidesIBA 01/2023 - 10/2008
3	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 03/2015
3	human ERBB2 proteinIBA 01/2021 - 03/2015
3	Oral ContraceptivesIBA 01/2021 - 12/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 07/2015
3	3' Untranslated Regions (3' UTR)IBA 01/2016 - 01/2014
3	Persistent Organic PollutantsIBA 06/2009 - 10/2004
3	Dichlorodiphenyl Dichloroethylene (DDE)IBA 02/2006 - 06/2003
3	Hexachlorobenzene (HCB)IBA 02/2006 - 06/2003
2	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 04/2015
2	AcidsIBA 01/2023 - 05/2002
2	mahuang-tangIBA 01/2022 - 12/2013
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 12/2021 - 01/2020
2	Trichloroethylene (Trichloroethene)IBA 10/2020 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2017
2	NucleotidesIBA 01/2019 - 01/2016
2	Ifosfamide FDA LinkGeneric 01/2018 - 10/2016
2	SolventsIBA 01/2018 - 12/2010
2	Petroleum (Crude Oil)IBA 01/2018 - 12/2010
2	Rituximab (Mabthera)FDA Link 11/2016 - 09/2009
2	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 07/2015
2	Cisplatin (Platino)FDA LinkGeneric 10/2016 - 07/2015
2	Etoposide (VP 16)FDA LinkGeneric 10/2016 - 05/2014
2	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2014
2	AntigensIBA 06/2014 - 06/2009
1	UromodulinIBA 02/2024
1	Blood Proteins (Serum Proteins)IBA 12/2023
1	MelatoninIBA 10/2023
1	A 7 (A-7)IBA 01/2023
1	Glyphosate (Roundup)IBA 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2022
1	AnticoagulantsIBA 05/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	4-hydroxy-N-desmethyltamoxifenIBA 01/2022
1	selinexorIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	InterferonsIBA 01/2022
1	Blood Alcohol ContentIBA 08/2021

Therapy/Procedure

20	Therapeutics 11/2023 - 08/2009
15	Drug Therapy (Chemotherapy) 11/2023 - 08/2003
7	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2021 - 12/2013
6	Radiotherapy 02/2023 - 12/2011
5	Stem Cell Transplantation 11/2016 - 08/2003
3	Critical Care (Surgical Intensive Care) 05/2022 - 01/2021
3	Adjuvant Chemotherapy 01/2018 - 08/2009
2	Resuscitation 12/2019 - 09/2015
2	Induction Chemotherapy 07/2015 - 08/2003
2	Neoadjuvant Therapy 06/2013 - 08/2009
1	Topical Administration 01/2022